| abstract |
The present invention relates to compounds and methods for treating neurological and other disorders by administering to a subject in need thereof an effective amount of a compound having binding and/or modulating specificity for GFRα receptor molecules, which may be a glial cell Mimetics of derived neurotrophic factor (GDNF) family ligands (GFL), agonists of the GFRα/RET signaling pathway, and/or direct RET agonists (activators). |